Abstract
Summary: Ocular manifestations in inborn errors of metabolism occur in many diseases and may be associated with any part of all eye components. In a minority of diseases it is possible to attribute the eye symptoms to a single hereditary pathogenetic mechanism. More often the aetiological relationship of the ocular defects to the metabolic disease is unknown. Diverse pathogenetic mechanisms may act via a common pathological pathway inducing ocular damage. The occurrence of eye abnormalities in metabolic disorders suggests that they are associated with direct toxic actions, errors of synthetic pathways or deficient energy metabolism. In this review, metabolic disorders with major abnormalities in the cornea, lens, retina and optic nerve are presented. In all cases, an appropriate combined approach by the ophthalmologist, paediatrician/neurologist, geneticist and clinical biochemist is the only way to diagnostic success.
Similar content being viewed by others
REFERENCES
Ai Y, Zheng Z, O'Brien-Jenkins A, et al (2000) A mouse model of galactose-induced cataracts. Hum Mol Genet 9: 1821-1827.
Ames A, Li Y-Y, Heher E, et al (1992) Energy metabolism of rabbit retina as related to function: high cost of sodium transport. J Neurosci 12: 840-853.
Anikster Y, Kleta R, Shaag A, et al (2001) Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet 69: 1218-1224.
Carelli V, Ross-Cisneros FN, Sadun AA (2002) Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 1169: 1-12.
Cenedella RJ (1996) Cholesterol and cataracts. Surv Ophthalmol 40: 320-327.
Costa T, Scriver CR, Childs B (1985) The effect of Mendelian disease on human health: a measurement. Am J Med Genet 21: 231-242.
Cross HE, Jensen AD (1973) Ocular manifestations in the Marfan syndrome and homocystinuria. Am J Ophthalmol 75: 405-420.
Cruysberg JR, Sengers RC, Pickers A, et al (1986) Features of a syndrome with congenital cataract and hypertrophic cardiomyopathy. Am J Ophthalmol 102: 740-749.
Cruysberg JR, Wevers RA, van Engelen BG, et al (1995) Ocular and systemic manifestations of cerebrotendinous xanthomatosis. Am J Ophthalmol 120: 597-604.
Drijja TP (2001) Retinitis pigmentosa and stationary night blindness. In Scriver CR, Baudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 5903 5933.
Duran M, Beemer FA, van der Heiden C, et al (1978) Combined deficiency of xanthine oxidase and sulphite oxidase: a defect of molybdenum metabolism or transport? J Inherit Metab Dis 1: 175 178.
Edwards MC, Johnson JL, Marriage B, et al (1999) Isolated sulfite oxidase deficiency: review of two cases in one family. Ophthalmology 106: 1957-1961.
Ei T, Whittum-Hudson JA, Mir SH, et al (2000) Microfibril abnormalities of the lens capsule in patients with Marfan syndrome and ectopia lentis. Ophthalmic Genet 21: 9-15.
Fleming CR, Dickson ER, Wahner HW, et al (1977) Pigmented rings in non-Wilsonian liver disease. Ann Intern Med 86: 285-288.
Frangois J (1979) Ocular manifestations in demyelinating diseases. Adv Ophthalmol 39: 1-36.
Freund C, Horsford DJ, McInnes RR (1996) Transcription factor genes and the developing eye: a genetic perspective. Hum Mol Genet 5: 1471-1488.
Hejtmancik JF, Kaiser MI, Piatigorsky J (2001) Molecular biology and inherited disorders of the eye lens. In Scriver CR, Baudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 6033 6061.
Howell N (1998) Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve. Vis Res 38: 1495-1504.
Kaiser-Kupfer MI, Caruso RC, Monkler DS, et al (1986) Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol 104: 706-711.
Lee AYW, Chung SK, Chung SSM (1995) Demonstration that polyol accumulation is respon-sible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA 92: 2780-2784.
Liu, M, Cohen EJ, Brewer GJ, et al (2002) Kayser-Fleischer ring as the presenting sign of Wilson disease. Am J Ophthalmol 133: 832-834.
Lueder GT, Steiner RD (1995) Ophthalmic abnormalities in molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. J Pediatr Ophthalmol Strabismus 32: 334-337.
Macsai MS, Schwartz TL, Hinkle D, et al (2001) Tyrosinemia type II: nine cases of ocular signs and symptoms. Am J Ophthalmol 132: 522-527.
Man PYW, Turnbull DM, Chinnery PF (2002) Leber hereditary optic neuropathy. JMed Genet 39: 162 169.
Maumenee IH (1982) The eye in the Marfan syndrome. Birth Defects 18: 515-524.
Nelson E (1971) Nosology of the leukodystrophies: ultrastructural contributions. Birth Defects Orig Artic Ser 1: 113-116.
OMIM (2001) Online Mendelian Inheritance in Man, Center for Medical Genetics, Johns Hopkins University, and National Center for Biotechnology Information, National Library of Medicine. http://www3.ncbi.nlm.nih.gov//omim Poll-The BT, Billette de Villemeur T, Abitol M, et al (1992) Metabolic pigmentary retinopathies: diagnosis and therapeutic attempts. Eur J Pediatr 151: 2-11.
Rattner A, Sun H, Nathans J (1999) Molecular genetics of human retinal disease. Annu Rev Genet 33: 89-131.
Saudubray JM, Charpentier C (2001) Clinical phenotypes: diagnosis/ algorithms. In Scriver CR, Baudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Meta-bolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1327 1403.
Silengo MC, Luzzatti L, Silverman FN (1980) Clinical and genetic aspects of Conradi Hiinermann disease. A report of three familial cases and review of the literature. J Pediatr 97: 911 917.
Stambolian D (1988) Galactosemia and cataract. Surv Ophthalmol 32: 333-349.
Sugar J (1979) Corneal manifestations of the systemic mucopolysaccharidoses. Ann Ophthalmol 11: 531 535.
Van Heyningen V (1998) Developmental eye disease a genome era paradigm. Clin Genet 54: 272-282.
Vergani L, Martinuzzi A, Carelli V, et al (1995) MtDNA mutations associated with Leber's hereditary optic neuropathy: studies on cytoplasmic hybrid (cybrid) cells. Biochem Biophys Res Commun 210: 880-888.
Votrula M, Aijaz S, Moore AT (2003) A review of primary hereditary optic neuropathies. J Inherit Metab Dis 26: 209-227.
Wallace DC, Singh OG, Lott MT, et al (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic atrophy. Science 242: 1427-1430.
Wang T, Milan AH, Steel G, et al (1996) A mouse model of gyrate atrophy of the choroid and retina: early pigment epithelium damage and progressive retinal degeneration. J Clin Invest 97: 2753-2762.
Wang T, Steel G, Milam AH, et al (2000) Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. Proc Natl Acad Sci USA 97: 1224-1229.
Yvert G, Lindenberg KS, Picaud S, et al (2000) Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA 7 transgenic mice. Hum Mol Genet 9: 2491-2506.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Poll-The, B.T., Maillette De Buy Wenniger-Prick, L.J., Barth, P.G. et al. The eye as a window to inborn errors of metabolism. J Inherit Metab Dis 26, 229–244 (2003). https://doi.org/10.1023/A:1024493318913
Issue Date:
DOI: https://doi.org/10.1023/A:1024493318913